Search

everythinglearnresearchcommunity

for

Search:↓

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Covid-19 can cause hair loss due to immune and psychological factors.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Low iron and vitamin B12 levels are common in women with chronic hair loss, while low vitamin D is less common.

MMP® with minoxidil may improve hair growth in chronic telogen effluvium.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

COVID-19 infection may cause hair loss.

People with chronic hair shedding had much lower vitamin D levels compared to healthy people.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

Many COVID-19 patients, especially women, experienced hair loss, often linked to diabetes and lack of dietary supplements.

Women with Telogen Effluvium have lower levels of Zinc and Iron in their hair.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Oral collagen combined with other treatments effectively reduces hair loss and improves hair quality in telogen effluvium.

COVID-19 increased hair loss, especially in women, linked to Azithromycin use and symptoms like fatigue and skin irritation.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Post-COVID-19 patients are at risk for hair loss.

COVID-19 infection is highly related to increased hair loss, especially in women.

Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.

COVID-19 infection may cause hair loss a few months after recovery.

Telogen effluvium is a condition that causes temporary hair loss.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

Trichoscopy is not specific for diagnosing telogen effluvium and both telogen effluvium and androgenetic alopecia often occur together.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.